Table 1.

Patient data and experimental tissue response.

#	Age	TNM (2017)	Grade	BRCA1/2	PS	ICD-O-C	Days in Culture	Treatment Period	Tissue Response
									CP	Ola
1	83	pT3c pN1a M0	G3	n.d.	-	57	≤14	-	-	-
3	62	pT3c pN0 M0	G3	n.d.	-	57	≤14	-	-	-
6	60	pT3a pN1a M0	G3	BRCA2mut	-	57	≤14	-	-	-
10	79	pT3c pN1b M0	G3	n.d.	+	57	≤7	72 h/6 d	R	R
11	67	pT3c pN1b M0	G3	no mut.	-	57	≤7	72 h/6 d	PR	PR
12	64	pT3c pN1b M0	G3	no mut.	-	57	4	72 h	NR	R
17	63	ypT3c ypN0 M0	G3	no mut.	+	56	4	72 h	PR	R
19	59	ypT3c ypN1 M0	G3	no mut.	+	56	4	72 h	NR	PR
20	53	pT3c pN0 M0	G3	no mut	+	56	4	72 h	NR	PR
22	60	pT3c pN0 M0	G3	no mut.	+	56	4	72 h	NR	NR

All patients were female. # = specimen number, PS = patient serum, 2% PS was added to the culture media. CP = carboplatin, Ola = olaparib, R = response, PR = partial response, NR = non-response, n.d. = no data, no mut. = no somatic mutation, mut = mutated.